Advertisement

AAPS PharmSciTech

, Volume 19, Issue 5, pp 2247–2254 | Cite as

Spray-Freeze Drying: a Suitable Method for Aerosol Delivery of Antibodies in the Presence of Trehalose and Cyclodextrins

  • Maryam Amini Pouya
  • Behnaz Daneshmand
  • Shabnam Aghababaie
  • Homa Faghihi
  • Alireza Vatanara
Research Article

Abstract

We aimed to prepare spray-freeze-dried powder of IgG considering physicochemical stability and aerodynamic aspects. Spray-freeze drying (SFD) exposes proteins to various stresses which should be compensated by suitable stabilizers. The competence of cyclodextrins (CDs), namely beta-cyclodextrin (βCD) and hydroxypropyl βCD (HPβCD), at very low concentrations, was investigated in the presence of separate mannitol- and trehalose-based formulations. Spray-freeze-dried preparations were quantified in terms of monomer recovery and conformation by size exclusion chromatography (SEC-HPLC) and Fourier transform infrared (FTIR) spectroscopy, respectively. Differential scanning calorimetry (DSC) and X-ray diffractometry (XRD) were employed to identify the thermal characteristics of powders. Particle morphology was visualized by scanning electron microscopy (SEM). Aerodynamic behavior of powders was checked through an Anderson cascade impactor (ACI). Although all formulations protected antibody from aggregation during the SFD process (aggregation < 1%), mannitol-containing ones failed upon the storage (19.54% in the worst case). Trehalose-HPβCD incomparably preserved the formulation with fine particle fraction (FPF) of 51.29%. Crystallization of mannitol resulted in IgG destabilization upon storage. Although employed concentration of CDs is too low (less than 50:1 molar ratio to protein), they successfully served as stabilizing agents in SFD with perfect improvement in aerosol functionality.

Graphical Abstract

KEY WORDS

IgG spray-freeze drying cyclodextrins trehalose stability aerodynamic property 

Abbreviations

IgG

Immunoglobulin G

SFD

Spray-freeze drying

CDs

Cyclodextrines

βCD

Beta-cyclodextrin

HPβCD

Hydroxypropyl beta-cyclodextrin

SEC-HPLC

Size exclusion high-performance liquid chromatography

FTIR

Fourier transform infrared

DSC

Differential scanning calorimetry

XRD

X-ray diffraction

SEM

Scanning electron microscopy

ACI

Anderson cascade impactor

FD

Freeze drying

SD

Spray drying

w/v

Weight/volume

Tg

Glass transition temperature

rhDNAse

Recombinant human deoxyribonuclease

HPMC

Hydroxypropyl methylcellulose

IVIG

Intravenous immunoglobulin

i.t.

Intratracheally

FPF

Fine particle fraction

LDH

Lactate dehydrogenase

References

  1. 1.
    Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. Int J Pharm. 1999;185(2):129–88.CrossRefPubMedGoogle Scholar
  2. 2.
    Maltesen MJ, van de Weert M. Drying methods for protein pharmaceuticals. Drug Discov Today Technol. 2008;5(2):e81–e8.CrossRefPubMedGoogle Scholar
  3. 3.
    Lim JY, Kim NA, Lim DG, Kim KH, Choi DH, Jeong SH. Process cycle development of freeze drying for therapeutic proteins with stability evaluation. J Pharm Investig. 2016;46(6):519–36.CrossRefGoogle Scholar
  4. 4.
    Dixit M, Kulkarni P, Selvam P. Review on: freeze drying as a crystallization technique. 2011;41(2011):5717–30.Google Scholar
  5. 5.
    Sonner C, Maa YF, Lee G. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability. J Pharm Sci. 2002;91(10):2122–39.CrossRefPubMedGoogle Scholar
  6. 6.
    Maa YF, Ameri M, Shu C, Payne LG, Chen D. Influenza vaccine powder formulation development: spray-freeze-drying and stability evaluation. J Pharm Sci. 2004;93(7):1912–23.CrossRefPubMedGoogle Scholar
  7. 7.
    Costantino HR, Firouzabadian L, Hogeland K, Wu C, Beganski C, Carrasquillo KG, et al. Protein spray-freeze drying. Effect of atomization conditions on particle size and stability. Pharm Res. 2000;17(11):1374–82.CrossRefPubMedGoogle Scholar
  8. 8.
    Maa Y-F, Nguyen P-A, Sweeney T, Shire SJ, Hsu CC. Protein inhalation powders: spray drying vs spray freeze drying. Pharm Res. 1999;16(2):249–54.CrossRefPubMedGoogle Scholar
  9. 9.
    Costantino HR, Firouzabadian L, Wu C, Carrasquillo KG, Griebenow K, Zale SE, et al. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J Pharm Sci. 2002;91(2):388–95.CrossRefPubMedGoogle Scholar
  10. 10.
    Nguyen XC, Herberger JD, Burke PA. Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa. Pharm Res. 2004;21(3):507–14.CrossRefPubMedGoogle Scholar
  11. 11.
    Maa Y-F, Costantino HR, Nguyen P-A, Hsu CC. The effect of operating and formulation variables on the morphology of spray-dried protein particles. Pharm Dev Technol. 1997;2(3):213–23.CrossRefPubMedGoogle Scholar
  12. 12.
    Izutsu K-i, Yoshioka S, Terao T. Decreased protein-stabilizing effects of cryoprotectants due to crystallization. Pharm Res. 1993;10(8):1232–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Heller MC, Carpenter JF, Randolph TW. Protein formulation and lyophilization cycle design: prevention of damage due to freeze-concentration induced phase separation. Biotechnol Bioeng. 1999;63(2):166–74.CrossRefPubMedGoogle Scholar
  14. 14.
    Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat Rev Drug Discov. 2005;4:298.CrossRefPubMedGoogle Scholar
  15. 15.
    Serno T, Geidobler R, Winter G. Protein stabilization by cyclodextrins in the liquid and dried state. Adv Drug Deliv Rev. 2011;63(13):1086–106.CrossRefPubMedGoogle Scholar
  16. 16.
    Hundre SY, Karthik P, Anandharamakrishnan C. Effect of whey protein isolate and β-cyclodextrin wall systems on stability of microencapsulated vanillin by spray–freeze drying method. Food Chem. 2015;174(Supplement C):16–24.CrossRefPubMedGoogle Scholar
  17. 17.
    Cheow WS, Ng MLL, Kho K, Hadinoto K. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants. Int J Pharm. 2011;404(1):289–300.CrossRefPubMedGoogle Scholar
  18. 18.
    Tavornvipas S, Hirayama F, Takeda S, Arima H, Uekama K. Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor. J Pharm Sci. 2006;95(12):2722–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Ramezani V, Vatanara A, Najafabadi AR, Shokrgozar MA, Khabiri A, Seyedabadi M. A comparative study on the physicochemical and biological stability of IgG1 and monoclonal antibodies during spray drying process. Daru. 2014;22(1):31.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Faghihi H, Khalili F, Amini M, Vatanara A. The effect of freeze-dried antibody concentrations on its stability in the presence of trehalose and hydroxypropyl-beta-cyclodextrin: a Box-Behnken statistical design. Pharm Dev Technol. 2017;22(6):724–32.CrossRefPubMedGoogle Scholar
  21. 21.
    Ramezani V, Vatanara A, Seyedabadi M, Nabi Meibodi M, Fanaei H. Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying. Drug Dev Ind Pharm. 2017;43(7):1103–11.CrossRefPubMedGoogle Scholar
  22. 22.
    Carpenter JF, Prestrelski SJ, Arakawa T. Separation of freezing- and drying-induced denaturation of lyophilized proteins using stress-specific stabilization. I. Enzyme activity and calorimetric studies. Arch Biochem Biophys. 1993;303(2):456–64.CrossRefPubMedGoogle Scholar
  23. 23.
    Tian F, Middaugh CR, Offerdahl T, Munson E, Sane S, Rytting JH. Spectroscopic evaluation of the stabilization of humanized monoclonal antibodies in amino acid formulations. Int J Pharm. 2007;335(1):20–31.CrossRefPubMedGoogle Scholar
  24. 24.
    Allison SD, Randolph TW, Manning MC, Middleton K, Davis A, Carpenter JF. Effects of drying methods and additives on structure and function of actin: mechanisms of dehydration-induced damage and its inhibition. Arch Biochem Biophys. 1998;358(1):171–81.CrossRefPubMedGoogle Scholar
  25. 25.
    Izutsu K, Yoshioka S, Terao T. Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying. Chem Pharm Bull. 1994;42(1):5–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Chang LL, Pikal MJ. Mechanisms of protein stabilization in the solid state. J Pharm Sci. 2009;98(9):2886–908.CrossRefPubMedGoogle Scholar
  27. 27.
    Allison SD, Chang B, Randolph TW, Carpenter JF. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch Biochem Biophys. 1999;365(2):289–98.CrossRefPubMedGoogle Scholar
  28. 28.
    Loftsson T, Jarho P, Masson M, Jarvinen T. Cyclodextrins in drug delivery. Expert Opin Drug Deliv. 2005;2(2):335–51.CrossRefPubMedGoogle Scholar
  29. 29.
    Srichana T, Suedee R, Reanmongkol W. Cyclodextrin as a potential drug carrier in salbutamol dry powder aerosols: the in-vitro deposition and toxicity studies of the complexes. Respir Med. 2001;95(6):513–9.CrossRefPubMedGoogle Scholar
  30. 30.
    Cabral Marques HM, Hadgraft J, Kellaway IW, Taylor G. Studies of cyclodextrin inclusion complexes. III. The pulmonary absorption of β-, DM-β- and HP-β-cyclodextrins in rabbits. Int J Pharm. 1991;77(2):297–302.CrossRefGoogle Scholar
  31. 31.
    Patton JS, Fishburn CS, Weers JG. The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc. 2004;1(4):338–44.CrossRefPubMedGoogle Scholar
  32. 32.
    Irie T, Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci. 1997;86(2):147–62.CrossRefPubMedGoogle Scholar
  33. 33.
    Asai K, Morishita M, Katsuta H, Hosoda S, Shinomiya K, Noro M, et al. The effects of water-soluble cyclodextrins on the histological integrity of the rat nasal mucosa. Int J Pharm. 2002;246(1–2):25–35.CrossRefPubMedGoogle Scholar
  34. 34.
    Chang BS, Kendrick BS, Carpenter JF. Surface-induced denaturation of proteins during freezing and its inhibition by surfactants. J Pharm Sci. 1996;85(12):1325–30.CrossRefPubMedGoogle Scholar
  35. 35.
    Lovatt M, Cooper A, Camilleri P. Energetics of cyclodextrin-induced dissociation of insulin. Eur Biophys J. 1996;24(5):354–7.CrossRefPubMedGoogle Scholar
  36. 36.
    Randolph TW. Phase separation of excipients during lyophilization: effects on protein stability. J Pharm Sci. 1997;86(11):1198–203.CrossRefPubMedGoogle Scholar
  37. 37.
    Santagapita PR, Brizuela LG, Mazzobre MF, Ramirez HL, Corti HR, Santana RV, et al. Structure/function relationships of several biopolymers as related to invertase stability in dehydrated systems. Biomacromolecules. 2008;9(2):741–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Fernández M, Villalonga ML, Fragoso A, Cao R, Villalonga R. Effect of β-cyclodextrin-polysucrose polymer on the stability properties of soluble trypsin. Enzym Microb Technol. 2004;34(1):78–82.CrossRefGoogle Scholar
  39. 39.
    Castellanos IJ, Flores G, Griebenow K. Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation. J Pharm Sci. 2006;95(4):849–58.CrossRefPubMedGoogle Scholar
  40. 40.
    Iwai J, Ogawa N, Nagase H, Endo T, Loftsson T, Ueda H. Effects of various cyclodextrins on the stability of freeze-dried lactate dehydrogenase. J Pharm Sci. 2007;96(11):3140–3.CrossRefPubMedGoogle Scholar
  41. 41.
    Del Valle EMM. Cyclodextrins and their uses: a review. Process Biochem. 2004;39(9):1033–46.CrossRefGoogle Scholar
  42. 42.
    Chefson A, Zhao J, Auclair K. Sugar-mediated lyoprotection of purified human CYP3A4 and CYP2D6. J Biotechnol. 2007;130(4):436–40.CrossRefPubMedGoogle Scholar
  43. 43.
    Hora MS, Rana RK, Smith FW. Lyophilized formulations of recombinant tumor necrosis factor. Pharm Res. 1992;9(1):33–6.CrossRefPubMedGoogle Scholar
  44. 44.
    Izutsu K, Yoshioka S, Terao T. Stabilizing effect of amphiphilic excipients on the freeze-thawing and freeze-drying of lactate dehydrogenase. Biotechnol Bioeng. 1994;43(11):1102–7.CrossRefPubMedGoogle Scholar
  45. 45.
    Ken-ichi I, Sumie Y, Tadao T. Stabilization of β-galactosidase by amphiphilic additives during freeze-drying. Int J Pharm. 1993;90(3):187–94.CrossRefGoogle Scholar
  46. 46.
    Wanning S, Süverkrüp R, Lamprecht A. Pharmaceutical spray freeze drying. Int J Pharm. 2015;488(1):136–53.CrossRefPubMedGoogle Scholar
  47. 47.
    Faghihi H, Merrikhihaghi S, Najafabadi A, Ramezani V, Sardari S, Vatanara A. A comparative study to evaluate the effect of different carbohydrates on the stability of immunoglobulin G during lyophilization and following storage. Pharm Sci. 2016;22(4):251–9.  https://doi.org/10.15171/PS.2016.39.CrossRefGoogle Scholar
  48. 48.
    Hooton JC, Jones MD, Price R. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach. J Pharm Sci. 2006;95(6):1288–97.CrossRefPubMedGoogle Scholar
  49. 49.
    Vozone CM, Marques HMC. Complexation of budesonide in cyclodextrins and particle aerodynamic characterization of the complex solid form for dry powder inhalation. J Incl Phenom Macrocycl Chem. 2002;44(1):111–6.CrossRefGoogle Scholar
  50. 50.
    Nimbalkar D, Birudaraj R, Jones PR, Smith TJ. Activation of diacetyldapsone and a preliminary evaluation of a cyclodextrin-diacetyldapsone complex in cultured lung cells. Biotechnol Appl Biochem. 2001;33(Pt 2):123–5.CrossRefPubMedGoogle Scholar
  51. 51.
    Matilainen L, Toropainen T, Vihola H, Hirvonen J, Järvinen T, Jarho P, Järvinen K. In vitro toxicity and permeation of cyclodextrins in Calu-3 cells. J Control Release. 2008;126(1):10–6.  https://doi.org/10.1016/j.jconrel.2007.11.003.

Copyright information

© American Association of Pharmaceutical Scientists 2018

Authors and Affiliations

  1. 1.Department of Pharmaceutics, Faculty of PharmacyTehran University of Medical SciencesTehranIran

Personalised recommendations